Follow BPI on Twitter
IIR’s 2nd Annual Business of Biosimilars conference delivers effective strategies to navigate scientific, regulatory, economic, and legal challenges you face to remain competitive in commercializing your biosimilar portfolio in the United States and abroad.
Visit Website
Facility Design Strategies for Single-Use Technologies
Please join us for a free webinar addressing strategies for facility design in biopharmaceutical manufacturing:
Wednesday, 29 February 2012
8:00 AM and 1:00 PM EST
Presented by:
Ingrid Long, MSc
Research Engineer
GE Healthcare Life Sciences
During the webinar, Ms. Long will discuss the impact of different strategies for facility design, with a focus on the following topics:
* Replacement of traditional equipment with the single-use equivalent
* Biopharmaceutical manufacturing in a single room
* Benefits of facility design with respect to cost, risk, and flexibility
Development of a Plant-Made Pharmaceutical Production Platform
Recommendations for Cell Banks Used in GXP Assays
Efficient Aggregate Removal from Impure Pharmaceutical Active Antibodies
Implementation of Single-Use Technology in Biopharmaceutical Manufacturing
Production and Purification of a PER.C6-Expressed IgM Antibody Therapeutic
How QbD and the FDA Process Validation Guidance Affect Product Development and Operations, Part 2